Ralph G Bennett

Learn More
OBJECTIVE To evaluate the safety of anakinra (a recombinant human interleukin-1 receptor antagonist) in a large population of patients with rheumatoid arthritis (RA), typical of those seen in(More)
OBJECTIVE To examine the safety of anakinra when added to a background of standard rheumatoid arthritis (RA) medications in patients with RA with active disease. METHODS This analysis further(More)
  • 1